SAVA Live signals | Maximize Profits with Getagraph.com

BUY 93625 min ago

@ $24.09

Issued: 14 Feb 2024 @ 15:43

Return: -18.47%

Previous signal: Feb 13 - 15:46

Previous signal: Sell

Return: 0.75 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Stats
Today's Volume	1.31M
Average Volume	722 185
Market Cap	848.94M
EPS	$0 ( 2024-02-27 )
Next earnings date	( $0 ) 2024-04-29
Last Dividend	$5.25 ( 2012-12-13 )
Next Dividend	$0 ( N/A )
P/E	-8.47
ATR14	$0.0400 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-17	Schoen Eric	Buy	1 500	Common Stock
2024-01-03	Schoen Eric	Buy	7 920	Common Stock Warrant
2024-04-17	Schoen Eric	Sell	1 000	Common Stock Warrant
2024-01-03	Schoen Eric	Buy	800	Common Stock Warrant
2023-12-06	Nicaise Claude	Buy	20 000	Stock Option (Right to Buy)

INSIDER POWER
79.72
Last 90 transactions
Buy: 1 768 041 \| Sell: 548 962

Volume Correlation

Long: 0.04 (neutral)

Short: -0.67 (moderate negative)

Signal:(40.264) Neutral

Cassava Sciences Inc Correlation

10 Most Positive Correlations
CBIO	0.848
GOOD	0.844
ALXO	0.828
ANGN	0.828
CTBI	0.825
MIRO	0.819
RPRX	0.813
CMPX	0.813
DCRC	0.808
BLUE	0.806

10 Most Negative Correlations
RNA	-0.87
VKTX	-0.844
BWMX	-0.833
MTRY	-0.832
DKDCA	-0.826
CFFE	-0.823
ROCL	-0.821
LRMR	-0.821
AMPH	-0.814
EDTX	-0.811

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cassava Sciences Inc Correlation - Currency/Commodity

0.49
( neutral )

0.58
( weak )

0.00
( neutral )

0.19
( neutral )

0.84
( strong )

-0.63
( weak negative )

Cassava Sciences Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.53M (0.00 %)
EPS:	$-2.32

Q4	2023
Revenue:	$2.35M
Gross Profit:	$1.99M (84.84 %)
EPS:	$-0.500

Q3	2023
Revenue:	$0
Gross Profit:	$-392 000 (0.00 %)
EPS:	$-0.610

Q2	2023
Revenue:	$0
Gross Profit:	$-391 000 (0.00 %)
EPS:	$-0.630

Financial Reports:

No articles found.

Cassava Sciences Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Cassava Sciences Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$14.00	2010-12-13
Last Dividend	$5.25	2012-12-13
Next Dividend	$0	N/A
Payout Date	2012-12-24
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$19.25	--
Avg. Dividend % Per Year	0.00%	--
Score	0.22	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-10-04)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.22

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2010	$14.00	37.20%
2011	$0	0.00%
2012	$5.25	19.20%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-40.28	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.624	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.560	1.500	-7.33	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	9.13	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	8.60	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	8.53	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-1.944	2.00	-0.648	-1.296	[0 - 30]
freeCashFlowPerShareTTM	-1.954	2.00	-0.977	-1.954	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.348	1.000	7.53	7.53	[0.2 - 0.8]
operatingProfitMarginTTM	-45.29	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.0155	0.800	-3.23	-2.58	[0.5 - 2]
Total Score				-1.853

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-10.93	1.000	-1.205	0	[1 - 100]
returnOnEquityTTM	-0.560	2.50	-4.71	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.954	2.00	-0.651	-1.954	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.944	2.00	-0.648	-1.296	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.968	1.500	0.215	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-34.93	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.35

Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.